Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Catalyst Pharmaceuticals (CPRX) Return on Invested Capital (2019 - 2025)

Catalyst Pharmaceuticals (CPRX) has disclosed Return on Invested Capital for 7 consecutive years, with 0.21% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Invested Capital fell 1.0% year-over-year to 0.21%, compared with a TTM value of 0.21% through Dec 2025, down 1.0%, and an annual FY2025 reading of 0.23%, down 3.0% over the prior year.
  • Return on Invested Capital was 0.21% for Q4 2025 at Catalyst Pharmaceuticals, down from 0.22% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.41% in Q1 2021 and bottomed at 0.08% in Q2 2024.
  • Average Return on Invested Capital over 5 years is 0.24%, with a median of 0.22% recorded in 2021.
  • The sharpest move saw Return on Invested Capital plummeted -31bps in 2021, then increased 15bps in 2022.
  • Year by year, Return on Invested Capital stood at 0.19% in 2021, then skyrocketed by 78bps to 0.34% in 2022, then plummeted by -61bps to 0.13% in 2023, then skyrocketed by 59bps to 0.21% in 2024, then dropped by -2bps to 0.21% in 2025.
  • Business Quant data shows Return on Invested Capital for CPRX at 0.21% in Q4 2025, 0.22% in Q3 2025, and 0.23% in Q2 2025.